{"id":"NCT00117338","sponsor":"Organon and Co","briefTitle":"A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)","officialTitle":"A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Pediatric Patients (Ages 6 to 14 Years) With Acute Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-07","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2005-07-06","resultsPosted":"2009-08-11","lastUpdate":"2024-05-10"},"enrollment":276,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"montelukast sodium","otherNames":["MK0476","SINGULAIRÂ®"]},{"type":"DRUG","name":"Comparator: placebo (unspecified)","otherNames":[]}],"arms":[{"label":"1","type":"PLACEBO_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone.","primaryOutcome":{"measure":"Improvement in FEV1 (Forced Expiratory Volume in 1 Second) Over the First 60 Minutes After Administration","timeFrame":"Baseline and (time weighted average over) 60 Minutes","effectByArm":[{"arm":"Montelukast Intravenous (IV) 5.25 mg","deltaMin":0.08,"sd":null},{"arm":"Placebo","deltaMin":0.07,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.775"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20306820"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2},"commonTop":["Any Respiratory, Thoracic And Mediastinal Disorders","Any Gastrointestinal Disorders","Asthma","Any Infections And Infestations","Any Nervous System Disorders"]}}